Biology Locomotion Movement part 7 (Striations in Muscle Fiber, Actin, Myosin) CBSE class 11 XI Biology Locomotion Movement part 7 (Striations in Muscle Fiber, Actin, Myosin) CBSE class 11 XI. By: ExamFearVideos … Continue reading →

Biology Locomotion Movement part 9 (Actin Myosin Structure) CBSE class 11 XI Biology Locomotion Movement part 9 (Actin Myosin Structure) CBSE class 11 XI. By: ExamFearVideos … Continue reading →

Biology Neural Control Coordination part 5 (Nematodes, Annelids, Arthropods) CBSE class 11 XI Biology Neural Control Coordination part 5 (Nervous System:Nematodes, Annelids, Arthropods) CBSE class 11 XI. By: ExamFearVideos … Continue reading →

GCSE Additional Science Biology Genetic Disorders Quiz link: https://docs.google.com/forms/d/1g4CFk9v1lsW1od3fzoxo0Ync2Y0hoawky34GMohkocY/viewform?usp=send_form. By: ABS Additional Science Biology … Continue reading →

Biology Neural Control Coordination part 14 (Impulse transmission : Synapse) CBSE class 11 XI Biology Neural Control Coordination part 14 (Impulse transmission : Synapse) CBSE class 11 XI. By: ExamFearVideos … Continue reading →

Biology and Ecology of Penaeus monodon 1 2 By: Hai NguyenDai … Continue reading →

AQA AS Biology 3.1.2 - Benedicts Test and Starch Test - http://www.examvault.net For more science resources visit: http://www.examvault.net For A-level Biology resources visit: http://www.examvault.net/biology1.html Produced by: ... By: ExamVault … Continue reading →

The first randomized, controlled trial on pharmacotherapy in primary ciliary dyskinesia is now in place IMAGE:This is the logo of EU-funded Bestcilia project. view more Credit: BESTCILIA | Better Experimental Screening and Treatment for Primary Ciliary Dyskinesia As is typical for orphan diseases, PCD has only been studied to a limited extent. Most therapeutic strategies are derived from research on other respiratory disorders. At present, all treatment is off-label, with no orphan drug available. BESTCILIA aims to perform the first randomized controlled trial (RCT) on pharmacotherapy in PCD in order to develop evidence-based treatment practices for the disease. A potential hope for maintenance prophylactic therapy for PCD is azithromycin (AZN): an antibiotic with a host of beneficial anti-infection properties. The trial will evaluate its efficacy and potential adverse effects in patients, with respect to such outcome measures as the pulmonary exacerbation rate and PCD-specific quality of life. Following a year of meticulous preparations BESTCILIA partners involved in this research have made it possible to commence the trial in 5 countries: Denmark, Germany, the Netherlands, Switzerland and the UK. Patient recruitment has been set in motion; particular success was noted in Denmark, with as many as 15 patients randomized and already … Continue reading →